Difference between revisions of "Lugli A, et al. Br. J. Cancer (2010) cited as Ref 702 in DOI: 10.1038/s41392-020-0110-5 (Q9965)"
Jump to navigation
Jump to search
(Created claim: title (P93): Prognostic impact of the expression of putative cancer stem cell markers CD133 CD166 CD44s EpCAM and ALDH1 in colorectal cancer, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 382-390, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 382-390 | ||
| Property / Page(s): 382-390 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:49, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Lugli A, et al. Br. J. Cancer (2010) cited as Ref 702 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Lugli A
0 references
2010
0 references
Br. J. Cancer
0 references
103
0 references
Prognostic impact of the expression of putative cancer stem cell markers CD133 CD166 CD44s EpCAM and ALDH1 in colorectal cancer (English)
0 references
382-390
0 references
